Endovascular Infusion of Lidocaine and Steroids in the Middle Meningeal Artery for Pain Management in Spontaneous Subarachnoid Hemorrhage Patients
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 2
SUMMARY
The goal of this clinical trial is to learn if an infusion of lidocaine, with or without steroids, into the middle meningeal artery (MMA) helps relieve severe headaches in patients with spontaneous subarachnoid hemorrhage (SAH). It will also study the safety of this treatment.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 100
Healthy Volunteers: f
View:
• Age ≥18 years.
• Diagnosed with aneurysmal SAH, Hunt and Hess Grades 1-2.
• Consent to study procedures and follow-up evaluations.
Locations
United States
Texas
University of Texas Medical Branch, Galveston
RECRUITING
Galveston
Contact Information
Primary
Matias Costa
mlcosta@utmb.edu
409-772-1011
Time Frame
Start Date: 2026-01-02
Estimated Completion Date: 2027-08
Participants
Target number of participants: 15
Treatments
Experimental: Lidocaine (50 mg bilaterally)
The participants will receive 50 mg of lidocaine.
Experimental: Lidocaine (50 mg) + Dexamethasone (10 mg bilaterally)
The participant will receive Lidocaine (50 mg) + Dexamethasone (10 mg bilaterally)
No_intervention: No injection (Control group)
The participant will not receive an injection.
Related Therapeutic Areas
Sponsors
Leads: The University of Texas Medical Branch, Galveston